Deutsche Bank AG Buys 29,558 Shares of Waters Co. (NYSE:WAT)

Deutsche Bank AG grew its position in shares of Waters Co. (NYSE:WAT - Free Report) by 12.5% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 266,947 shares of the medical instruments supplier's stock after purchasing an additional 29,558 shares during the period. Deutsche Bank AG owned approximately 0.45% of Waters worth $99,032,000 at the end of the most recent reporting period.

Several other large investors have also recently made changes to their positions in the company. Advisory Alpha LLC increased its holdings in Waters by 2.6% during the fourth quarter. Advisory Alpha LLC now owns 1,065 shares of the medical instruments supplier's stock valued at $395,000 after buying an additional 27 shares during the period. Empowered Funds LLC boosted its position in Waters by 3.0% during the 4th quarter. Empowered Funds LLC now owns 966 shares of the medical instruments supplier's stock valued at $358,000 after acquiring an additional 28 shares in the last quarter. Deroy & Devereaux Private Investment Counsel Inc. increased its holdings in shares of Waters by 0.3% in the 4th quarter. Deroy & Devereaux Private Investment Counsel Inc. now owns 9,610 shares of the medical instruments supplier's stock valued at $3,565,000 after acquiring an additional 30 shares during the period. Blue Trust Inc. raised its position in shares of Waters by 9.6% in the 4th quarter. Blue Trust Inc. now owns 353 shares of the medical instruments supplier's stock worth $127,000 after acquiring an additional 31 shares in the last quarter. Finally, Larson Financial Group LLC lifted its stake in shares of Waters by 6.8% during the 4th quarter. Larson Financial Group LLC now owns 537 shares of the medical instruments supplier's stock worth $199,000 after purchasing an additional 34 shares during the last quarter. 94.01% of the stock is owned by institutional investors.

Analyst Ratings Changes

WAT has been the topic of several analyst reports. Sanford C. Bernstein set a $400.00 target price on Waters and gave the company an "outperform" rating in a research note on Wednesday, April 16th. KeyCorp raised shares of Waters from a "sector weight" rating to an "overweight" rating and set a $460.00 price objective on the stock in a research report on Monday, March 31st. Robert W. Baird increased their target price on shares of Waters from $355.00 to $374.00 and gave the company an "outperform" rating in a research report on Wednesday, May 7th. Barclays lowered their target price on shares of Waters from $400.00 to $350.00 and set an "equal weight" rating for the company in a research note on Thursday, April 10th. Finally, UBS Group reduced their price target on Waters from $415.00 to $360.00 and set a "neutral" rating on the stock in a research report on Wednesday, May 7th. Ten analysts have rated the stock with a hold rating, seven have issued a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average target price of $390.19.

Waters Trading Down 2.0%

Waters stock opened at $343.73 on Monday. The stock has a 50-day moving average price of $349.55 and a 200 day moving average price of $370.42. The company has a market capitalization of $20.46 billion, a price-to-earnings ratio of 32.09, a price-to-earnings-growth ratio of 3.79 and a beta of 1.14. Waters Co. has a 52 week low of $279.24 and a 52 week high of $423.56. The company has a quick ratio of 0.65, a current ratio of 0.94 and a debt-to-equity ratio of 1.14.

Waters (NYSE:WAT - Get Free Report) last posted its quarterly earnings results on Tuesday, May 6th. The medical instruments supplier reported $2.25 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $2.22 by $0.03. The company had revenue of $661.71 million during the quarter, compared to analyst estimates of $655.50 million. Waters had a net margin of 21.56% and a return on equity of 46.31%. Waters's revenue for the quarter was up 3.9% compared to the same quarter last year. During the same period last year, the firm posted $2.21 EPS. Sell-side analysts anticipate that Waters Co. will post 12.86 EPS for the current year.

Waters Profile

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.